Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Life Science Awards.
Sort by 
Women in Pharma’s Miriam Kenrick: my career so far
Author: Chris Wheal
Miriam Kenrick is co-founder of Women in Pharma but for her day job she is vice president marketing EMEA at eye health specialist Santen. Pharma News caught up with to find who and what inspired her.
Do bad bosses stop you doing good deeds?
Author: Chris Wheal
Mean or abusive bosses can harm their employees’ desire to do good deeds outside the workplace, research from Dublin’s Trinity Business School has revealed. But do we believe them?
AstraZeneca opens up on pharmaceuticals in the environment (PIE)
Author: Chris Wheal
AstraZeneca has issued an update on its activities to contain and reduce pharmaceuticals in the environment (PIE).
No let-up in net zero as most sectors ‘not on track’
Author: Chris Wheal
The UK’s Climate Change Committee has warned the government against putting the brakes on its drive towards net zero by carrying forward surplus emissions from its latest carbon budget.
Next generation to study AI in drugs and medicine
Author: Chris Wheal
Two university courses in London and Dublin aim to tackle the skills shortage in artificial intelligence within the pharmaceutical sector.
Hacker attacks and the valuable pharma sector data
Author: Chris Wheal
Pharma companies are hit by just 4% of cyberattacks but face the third highest costs as a result.
Diaceutics’ Ken Ruppel: my career so far
Author: Chris Wheal
Ken Ruppel joined Belfast and London R&D diagnostics and precision medicine firm Diaceutics in February as VP of scientific and medical services. Pharma News caught up with him to find out about his career.
Greenwashing and guilt by association hit sustainability claims
Author: Chris Wheal
It is no longer good enough to make sustainability claims. Companies must provide evidence and back up their rhetoric with actions.
Which pharma firm might join the GRANOLAS?
Author: Chris Wheal
Several healthcare firms are similar to Goldman Sach's GRANOLAS group of high-performing European stocks and these listings change and grow, so which company might join the prestigious group?
Health tech start-ups struggle to attract venture capital
Author: Chris Wheal
Health tech innovation has taken a hit since Covid pandemic highs, with venture capital funding for digital health initiatives halving for the second year running.
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
